NEW YORK (GenomeWeb News) – Researchers at the Biodesign Institute at Arizona State University and Phoenix Children's Hospital will team up to use genome sequencing to study the molecular basis of desmoplastic small round cell tumor (DSRCT), a deadly pediatric cancer.

The three-year project, funded with a $250,000 grant from the non-profit Hyundai Hope on Wheels organization, will fund genome sequencing efforts at the Center for Personalized Diagnostics at the Biodesign Institute and bioinformatic analyses of pediatric DSRCT tumor samples, ASU said this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.